CD20-positive Non-Hodgkin Lymphoma

Also known as: CD20 Positive Non Hodgkin Lymphoma

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB18492	CPO-107	1 / 2	Suspended	1
DB00073	Rituximab	2	Terminated	1